<status value="active"/> <date value="2026-03-18"/> <author> <name value="Khalid Shahin"/> </author> <publisher value="HL7 International / Clinical Decision Support"/> <contact> <name value="HL7 International / Clinical Decision Support"/> <telecom> <system value="url"/> <value value="http://www.hl7.org/Special/committees/dss"/> </telecom> </contact> <description value="Time to first occurrence of any of: myocardial infarction, other acute coronary syndrome, stroke, acute decompensated heart failure, or death from cardiovascular causes. Each component event is adjudicated by a committee unaware of treatment assignment."/> <copyright value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/> </EvidenceVariable>

Generated Narrative: EvidenceVariable 588221

version: 1; Last updated: 2026-08-07 02:39:31+0000

ArtifactPublicationStatus: Active

url: EvidenceVariable Major adverse cardiovascular events (composite endpoint)

identifier: FEvIR Object Identifier/588221, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.120

version: 1.0.0-ballot3

name: Major_adverse_cardiovascular_events_composite_endpoint

title: Major adverse cardiovascular events (composite endpoint)

status: Active

date: 2026-03-18

author: Khalid Shahin:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Time to first occurrence of any of: myocardial infarction, other acute coronary syndrome, stroke, acute decompensated heart failure, or death from cardiovascular causes. Each component event is adjudicated by a committee unaware of treatment assignment.

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).